Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
HVIVO Aktie jetzt für 0€ handeln | |||||
12.12. | hVIVO reports breakthrough in COVID-19 biomarker study | 2 | Investing.com | ||
12.12. | hVIVO PLC - COVID-19 study published in Nature Communications | - | RNS | ||
10.12. | Hvivo strikes £11.5m RSV contract with existing client | 2 | Sharecast | ||
10.12. | hVIVO PLC - £11.5m RSV contract and notice of trading update | - | RNS | ||
05.11. | hVIVO PLC - Presentation at Jefferies London Healthcare Conf | 1 | RNS | ||
11.10. | hVIVO PLC - Long Term Incentive Plan/ PDMR Notification | - | RNS | ||
07.10. | hVIVO upbeat on positive human challenge trial results with client | 1 | Sharecast | ||
07.10. | hVIVO PLC - Positive results from RSV human challenge trial | 1 | RNS | ||
30.09. | hVIVO gets HSE clearance, launches new lab services | 2 | Sharecast | ||
30.09. | hVIVO PLC - Launch of full suite of hLAB standalone services | - | RNS | ||
10.09. | hVIVO hails "record" half-year revenue, as profit soars 70% higher | 2 | Alliance News | ||
10.09. | Clinical trial specialist hVivo's H1 revenues jump by 30% | 1 | RTE.ie | ||
10.09. | hVIVO PLC - Interim results | 1 | RNS | ||
20.08. | hVIVO PLC - Notice of results | 2 | RNS | ||
05.08. | JD Wetherspoon chair offloads 1% stake while hVIVO chair exits the register | Directors Deals | 1 | Shares | ||
05.08. | Life sciences firm hVIVO cancels Euronext listing to focus on London | 1 | City A.M. | ||
05.08. | Three Quick Facts: UK Oil & Gas, Clarkson, hVIVO | 1 | The Armchair Trader | ||
05.08. | hVIVO PLC - Euronext cancellation | - | RNS | ||
23.07. | hVIVO PLC - Director/PDMR Shareholding | - | RNS | ||
17.07. | hVivo expects half year revenues to rise by 30% | 1 | RTE.ie |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
PLUS THERAPEUTICS | 0,998 | -3,67 % | Plus Therapeutics Inc.: Plus Therapeutics Presents Positive ReSPECT-LM Phase 1 Interim Data for Breast Cancer Patients with Leptomeningeal Metastases at the 2024 San Antonio Breast Cancer Symposium | ||
SPINEWAY | 0,081 | -0,49 % | Spineway wins new approvals in Vietnam and registers initial orders | Press release Ecully, December 18, 2024 - 6 p.m. Spineway wins new approvals in Vietnam and registers initial orders The Spineway Group, a specialist in innovative implants for the treatment... ► Artikel lesen | |
ASENSUS SURGICAL | 0,305 | 0,00 % | KARL STORZ akquiriert den US-amerikanischen Robotik-Spezialisten Asensus Surgical | Tuttlingen / Research Triangle Park, USA (ots) - Das familiengeführte und international agierende Medizintechnikunternehmen KARL STORZ gibt die Akquisition des innovativen Robotik-Spezialisten Asensus... ► Artikel lesen | |
MEDIVOLVE | 0,003 | 0,00 % | Medivolve Inc (2): Medivolve president, CEO Preiner resigns | ||
LIFEWARD | 1,470 | -1,34 % | Lifeward-Direktor Joseph Turk erwirbt Unternehmensaktien im Wert von 10.140 US-Dollar | ||
JD HEALTH | 3,520 | -0,56 % | JD Health-Aktie: Kurs legt zu (3,50 €) | Die Aktie von JD Health notiert am Freitag fester. Das Papier kostete zuletzt 3,50 Euro. Freuen können sich gegenwärtig die Aktionäre von JD Health: Das Wertpapier weist aktuell einen Preisanstieg von... ► Artikel lesen | |
EKSO BIONICS | 0,592 | -0,34 % | Ekso Bionics Holdings, Inc.: Ekso Bionics Announces Third Quarter 2024 Financial Results | SAN RAFAEL, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the "Company"), an industry leader in exoskeleton technology for medical and industrial use, today... ► Artikel lesen | |
IMUNON | 0,810 | +1,25 % | Imunon, Inc.: IMUNON Announces Positive CMC Meeting with FDA for IMNN-001 in Treatment of Advanced Ovarian Cancer | Company aligned with FDA on CMC strategy and requirements in preparation of Phase 3 pivotal trial of IMNN-001 Vertical integration of major components assures a high-quality, commercially viable future... ► Artikel lesen | |
ROCKWELL MEDICAL | 1,916 | -3,67 % | Aktien New York Ausblick: Verluste erwartet - Konjunkturdaten und Fed im Fokus | NEW YORK (dpa-AFX) - An den US-Börsen bahnt sich am Dienstag für den Dow Jones Industrial der neunte Schwächetag in Folge an. Die überwiegend mit Technologiewerten bestückte Nasdaq dürfte nach einem... ► Artikel lesen | |
AVINGER | 0,490 | -31,47 % | Avinger Inc - 8-K, Current Report | ||
VIRIDIAN THERAPEUTICS | 18,000 | -1,64 % | Viridian Therapeutics (NASDAQ:VRDN) Shares Gap Down - Time to Sell? | ||
SINTX TECHNOLOGIES | 3,870 | +5,74 % | SINTX Technologies, Inc.: SINTX Technologies Provides Positive Strategic Business Update for Q3 2024 | Salt Lake City, UT, Nov. 14, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) ("SINTX" or the "Company"), an advanced ceramics company that develops and commercializes materials, components... ► Artikel lesen | |
AETHLON MEDICAL | 0,550 | +0,92 % | AETHLON MEDICAL INC - 8-K, Current Report | ||
STAGEZERO LIFE SCIENCES | 0,028 | 0,00 % | Stagezero Life Sciences Ltd (2): Stagezero loses $1.43-million (U.S.) in nine months | ||
NEURONETICS | 1,318 | +5,95 % | Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | MALVERN, Pa., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the "Company") today announced the granting of inducement awards to new employees as described below. In accordance... ► Artikel lesen |